The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
Transplantation is a life-saving procedure in the case of organ failure (e.g. end-stage renal disease). While there is an established clinical practice, the overall number of transplants performed is limited by the availability of organs. The European Union has been working towards improving the organ transplantation process and addressing the shortage of organs for transplantation.
In 2019, the EU passed a directive on the quality and safety of human organs intended for transplantation. The directive sets out common quality and safety standards for the procurement, testing, preservation, and storage of organs across the EU Member States. The aim of this directive is to ensure that all organs used for transplantation meet high safety and quality standards. The highest number of transplants are kidney transplants, followed by liver and heart transplants. According to data from the European Union, in 2021, there were over 36,000 organ transplants carried out in the EU, yet there were over 41,000 new patients registered on the waiting list. This suggests that many persons who need a transplant are still waiting for a suitable donor organ.
As the demand for organs exceeds the supply, some individuals may still die while waiting for a suitable donor organ to become available. This shortage is exacerbated by the reluctance of some individuals and families to donate organs, as well as the lack of an effective system for identifying potential donors. Another challenge is the lack of coordination and standardisation among EU Member States. This can lead to inconsistencies in the quality and safety of transplanted organs, and can also make it more difficult to share organs between countries.
Join this EURACTIV Hybrid Conference to discuss how to empower transplant patients, facilitating a meaningful dialogue between organ donors and their families, caregivers and transplant professionals. Questions to be discussed include:
This campaign is possible thanks to an unrestricted grant provided by Chiesi.
Schedule
17:00 – 17:30 Registration of Participants
17:30 – 17:35 Welcome
17:35 – 17:50 Panellist statements
17:50 – 18:40 Discussion and Q&A
18:40 – 18:45 Closing statements
PANELLISTS
Tomislav Sokol MEP
Substitute, Subcommittee on Public Health, European Parliament
Anna Forsberg
Professor at Lund University
Daniel Gallego
President of the European Kidney Patient’s Federation (EKPF) and Representative of Steering Committee, Patient Inclusion Initiatives ESOT, European Society of Organ Transplantation (ESOT)
Carmen Dell’Anna
Head of Global Medical Affairs, Chiesi
MODERATOR
Jennifer Baker
EURACTIV